{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:44:16Z","timestamp":1794714256882,"version":"4.9.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Trial teams frequently make language-related, non-clinical eligibility decisions during recruitment. They need to ensure that patients understand the conditions and implications of trial participation and either have the necessary language skills to participate, or receive appropriate accommodations (e.g. translation or interpreting). Fair and consistent assessments are necessary to avoid unduly excluding patients, which could limit external validity and exacerbate inequalities. This study examines how trial teams make language-related eligibility decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review of National Institute for Health and Care Research (NIHR) research reports (2010\u20132022) for UK-based randomised controlled trials (RCTs) recruiting adults for two conditions that disproportionately affect ethnic minority populations: clinical depression and type 2 diabetes mellitus (T2DM). Two researchers independently screened titles and abstracts and extracted data. We analysed the communication demands of the interventions and primary outcome measures in relation to how language screening was reported, including procedures or instruments used as proxies for language-related gatekeeping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We assessed 185 titles and abstracts from NIHR monographs. Thirty-two RCTs (23 depression, 9 T2DM) ultimately met our inclusion criteria. Ethnic diversity was minimal, particularly in the depression RCTs, where the median proportion of White participants was 97%. Language screening practices were inconsistent across studies and were often poorly aligned with the actual linguistic demands of the trial. Half of the included RCTs explicitly reported a language-based eligibility criterion, including 63% of trials evaluating talking therapies for depression compared to 27% of trials assessing pharmacological, device-based, or surgical interventions. Explicit and implicit language-related gatekeeping measures included the ability to complete research assessments involving language (sometimes to a prespecified score cut-point), provide informed consent, and engage in the intervention as judged by recruiters. Translation and interpreting support were mentioned in one depression study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This review exposes methodological practices that may impede diverse patients\u2019 participation. Linguistic demands of the interventions and outcomes need to be considered in justifying language-related screening and accommodations. Participants\u2019 language variables need to be disentangled from ethnicity through routine data collection. A purpose-built screening tool that is universally applied to all participants could lead to fairer, more consistent assessments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      PROSPERO International Prospective Register of Systematic Reviews CRD42021267905.\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=267905\" ext-link-type=\"uri\">https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=267905<\/jats:ext-link>\n                      . Registered on\u00a0October 21 2021.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-026-09766-5","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:05:16Z","timestamp":1778907916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Language-related eligibility criteria in UK randomised trials: a systematic review of extended research reports"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4302-3379","authenticated-orcid":false,"given":"Talia","family":"Isaacs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3340-7435","authenticated-orcid":false,"given":"Andrea","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3445-6861","authenticated-orcid":false,"given":"Zs\u00f3fia","family":"Demj\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8173-1993","authenticated-orcid":false,"given":"Marie-Anne","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7890-2854","authenticated-orcid":false,"given":"Katie","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2343-7099","authenticated-orcid":false,"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3426-6408","authenticated-orcid":false,"given":"Nurulamin M.","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0969-8321","authenticated-orcid":false,"given":"Frances","family":"Shiely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9323-1371","authenticated-orcid":false,"given":"Matthew R.","family":"Sydes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7239-7241","authenticated-orcid":false,"given":"Shaun","family":"Treweek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4468-7417","authenticated-orcid":false,"given":"Katie","family":"Biggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"1","key":"9766_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/mpr.1434","volume":"23","author":"G Brown","year":"2014","unstructured":"Brown G, Marshall M, Bower P, Woodham A, Waheed W. Barriers to recruiting ethnic minorities to mental health research: A systematic review. Int J Methods Psychiatr Res. 2014;23(1):36\u201348.","journal-title":"Int J Methods Psychiatr Res"},{"issue":"1","key":"9766_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02809-7","volume":"21","author":"M Murali","year":"2023","unstructured":"Murali M, Gumber L, Jethwa H, Ganesh D, Hartmann-Boyce J, Sood H, et al. Ethnic minority representation in UK COVID-19 trials: systematic review and meta-analysis. BMC Med. 2023;21(1):111.","journal-title":"BMC Med"},{"key":"9766_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2025.101475","volume":"45","author":"C Vindrola-Padros","year":"2025","unstructured":"Vindrola-Padros C, Gilchrist K, Braverman S, Omar R, Merivale E, Hussenbux A, et al. A mixed-methods study on the recruitment of patients from ethnic minority groups to clinical trials in a central London teaching hospital. Contemp Clin Trials Commun. 2025;45:101475.","journal-title":"Contemp Clin Trials Commun"},{"issue":"11","key":"9766_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-043634","volume":"10","author":"MD Witham","year":"2020","unstructured":"Witham MD, Anderson E, Carroll CB, Dark PM, Down K, Hall AS, et al. Ensuring that COVID-19 research is inclusive: Guidance from the NIHR INCLUDE project. BMJ Open. 2020;10(11):e043634.","journal-title":"BMJ Open"},{"issue":"10242","key":"9766_CR5","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/S0140-6736(20)31380-5","volume":"395","author":"S Treweek","year":"2020","unstructured":"Treweek S, Forouhi NG, Narayan KMV, Khunti K. COVID-19 and ethnicity: Who will research results apply to? Lancet. 2020;395(10242):1955\u20137.","journal-title":"Lancet"},{"issue":"1","key":"9766_CR6","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1186\/s13063-020-04613-7","volume":"21","author":"MD Witham","year":"2020","unstructured":"Witham MD, Anderson E, Carroll C, Dark PM, Down K, Hall AS, et al. Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process. Trials. 2020;21(1):694.","journal-title":"Trials"},{"issue":"3","key":"9766_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/bjc.2014.303","volume":"111","author":"ME Abdel-Rahman","year":"2014","unstructured":"Abdel-Rahman ME, Butler J, Sydes MR, Parmar MK, Gordon E, Harper P, et al. No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials. Br J Cancer. 2014;111(3):589\u201397.","journal-title":"Br J Cancer"},{"issue":"1","key":"9766_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s13063-021-05276-8","volume":"22","author":"S Treweek","year":"2021","unstructured":"Treweek S, Banister K, Bower P, Cotton S, Devane D, Gardner HR, et al. Developing the INCLUDE Ethnicity Framework: a tool to help trialists design trials that better reflect the communities they serve. Trials. 2021;22(1):337.","journal-title":"Trials"},{"issue":"1","key":"9766_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06553-w","volume":"23","author":"S Dawson","year":"2022","unstructured":"Dawson S, Banister K, Biggs K, Cotton S, Devane D, Gardner H, et al. Trial Forge Guidance 3: randomised trials and how to recruit and retain individuals from ethnic minority groups\u2014practical guidance to support better practice. Trials. 2022;23(1):672.","journal-title":"Trials"},{"issue":"9","key":"9766_CR10","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1056\/NEJMra1411250","volume":"372","author":"C Grady","year":"2015","unstructured":"Grady C. Enduring and emerging challenges of informed consent. N Engl J Med. 2015;372(9):855\u201362.","journal-title":"N Engl J Med"},{"issue":"9","key":"9766_CR11","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6374","volume":"18","author":"T Isaacs","year":"2016","unstructured":"Isaacs T, Hunt D, Ward D, Rooshenas L, Edwards L. The inclusion of ethnic minority patients and the role of language in telehealth trials for type 2 diabetes: a systematic review. J Med Internet Res. 2016;18(9):e256.","journal-title":"J Med Internet Res"},{"issue":"4","key":"9766_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1177\/0261927X09341950","volume":"28","author":"O Kang","year":"2009","unstructured":"Kang O, Rubin DL. Reverse linguistic stereotyping: measuring the effect of listener expectations on speech evaluation. J Lang Soc Psychol. 2009;28(4):441\u201356.","journal-title":"J Lang Soc Psychol"},{"issue":"4","key":"9766_CR13","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1017\/S1366728912000168","volume":"15","author":"P Trofimovich","year":"2012","unstructured":"Trofimovich P, Isaacs T. Disentangling accent from comprehensibility. Biling Lang Cogn. 2012;15(4):905\u201316.","journal-title":"Biling Lang Cogn"},{"issue":"1","key":"9766_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/tesq.3041","volume":"56","author":"T Isaacs","year":"2021","unstructured":"Isaacs T, Rose H. Redressing the balance in the native speaker debate: assessment standards, standard language, and exposing double standards. TESOL Q. 2021;56(1):401\u201312.","journal-title":"TESOL Q"},{"key":"9766_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111259","volume":"167","author":"J dos Santos","year":"2024","unstructured":"dos Santos J, Dawson S, Conefrey C, Isaacs T, Khanum M, Faisal S, et al. Most UK cardiovascular disease trial protocols feature criteria that exclude ethnic minority participants: a systematic review. J Clin Epidemiol. 2024;167:111259.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"9766_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/dme.13103","volume":"34","author":"K Khunti","year":"2017","unstructured":"Khunti K, Bellary S, Karamat MA, Patel K, Patel V, Jones A, et al. Representation of people of South Asian origin in cardiovascular outcome trials of glucose-lowering therapies in type 2 diabetes. Diabet Med. 2017;34(1):64\u20138.","journal-title":"Diabet Med"},{"issue":"9","key":"9766_CR17","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1017\/S0033291714002967","volume":"45","author":"ED Williams","year":"2015","unstructured":"Williams ED, Tillin T, Richards M, Tuson C, Chaturvedi N, Hughes AD, et al. Depressive symptoms are doubled in older British South Asian and Black Caribbean people compared with Europeans: associations with excess co-morbidity and socioeconomic disadvantage. Psychol Med. 2015;45(9):1861\u201371.","journal-title":"Psychol Med"},{"key":"9766_CR18","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.","edition":"5th ed"},{"issue":"2","key":"9766_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/00856401.2017.1293918","volume":"40","author":"B Singh","year":"2017","unstructured":"Singh B. Depression. South Asia J South Asian Stud. 2017;40(2):297\u2013300.","journal-title":"South Asia J South Asian Stud"},{"key":"9766_CR20","doi-asserted-by":"crossref","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, editors. Cochrane handbook for systematic reviews of interventions. 2nd ed. Chichester (UK): John Wiley & Sons; 2019.","DOI":"10.1002\/9781119536604"},{"key":"9766_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"9766_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j3453","volume":"358","author":"S Staniszewska","year":"2017","unstructured":"Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, et al. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. BMJ. 2017;358:j3453.","journal-title":"BMJ"},{"issue":"6","key":"9766_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.7861\/clinmedicine.16-6-501","volume":"16","author":"SC Davies","year":"2016","unstructured":"Davies SC, Walley T, Smye S, Cotterill L, Whitty CJ. The NIHR at 10: transforming clinical research. Clin Med. 2016;16(6):501\u20132. https:\/\/doi.org\/10.7861\/clinmedicine.16-6-501.","journal-title":"Clin Med"},{"key":"9766_CR24","unstructured":"National Institute for Health and Care Research (NIHR). Inclusive research funding application guidance 2024. Internet. 2025. Available from: https:\/\/www.nihr.ac.uk\/about-us\/who-we-are\/research-inclusion\/funding-application-guidance"},{"key":"9766_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081124","volume":"389","author":"S Hopewell","year":"2025","unstructured":"Hopewell S, Chan A-W, Collins GS, Hr\u00f3bjartsson A, Moher D, Schulz KF, et al. CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials. BMJ. 2025;389:e081124.","journal-title":"BMJ"},{"issue":"5","key":"9766_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3102\/0013189X018002005","volume":"18","author":"S Messick","year":"1989","unstructured":"Messick S. Meaning and values in test validation: the science and ethics of assessment. Educ Res. 1989;18(5):5\u201311.","journal-title":"Educ Res"},{"key":"9766_CR27","doi-asserted-by":"crossref","unstructured":"Sharp DJ, Chew-Graham C, Tylee A, Lewis G, Howard L, Anderson I, et al. A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial. Health Technol Assess. 2010;14(43).","DOI":"10.3310\/hta14430"},{"key":"9766_CR28","doi-asserted-by":"crossref","unstructured":"Chalder M, Wiles NJ, Campbell J, Hollinghurst SP, Searle A, Haase AM, et al. A pragmatic randomised controlled trial to evaluate the cost-effectiveness of a physical activity intervention as a treatment for depression: the treating depression with physical activity (TREAD) trial. Health Technol Assess. 2012;16(10).","DOI":"10.3310\/hta16100"},{"key":"9766_CR29","doi-asserted-by":"crossref","unstructured":"Bedson E, Bell D, Carr D, Carter B, Hughes D, Jorgensen A, et al. Folate augmentation of treatment\u2014evaluation for depression (FolATED): randomised trial and economic evaluation. Health Technol Assess. 2014;18(48).","DOI":"10.3310\/hta18480"},{"key":"9766_CR30","doi-asserted-by":"crossref","unstructured":"Wiles N, Thomas L, Abel A, Barnes M, Carroll F, Ridgway N, et al. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial. Health Technol Assess. 2014;18(31).","DOI":"10.3310\/hta18310"},{"key":"9766_CR31","doi-asserted-by":"crossref","unstructured":"Ferrier IN, Anderson IM, Barnes J, Gallagher P, Grunze HCR, Haddad PM, et al.; ADD Study Team. Randomised controlled trial of antiglucocorticoid augmentation (metyrapone) of antidepressants in depression (ADD study). Efficacy Mech Eval. 2015;2(4).","DOI":"10.3310\/eme02040"},{"key":"9766_CR32","doi-asserted-by":"crossref","unstructured":"Kuyken W, Hayes R, Barrett B, Byng R, Dalgleish T, Kessler D, et al. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence: results of a randomised controlled trial (the PREVENT study). Health Technol Assess. 2015;19(73).","DOI":"10.3310\/hta19730"},{"key":"9766_CR33","doi-asserted-by":"crossref","unstructured":"Littlewood E, Duarte A, Hewitt C, Knowles S, Palmer S, Walker S, et al.; REEACT Team. A randomised controlled trial of computerised cognitive behaviour therapy for the treatment of depression in primary care: the randomised evaluation of the effectiveness and acceptability of computerised therapy (REEACT) trial. Health Technol Assess. 2015;19(101).","DOI":"10.3310\/hta191010"},{"key":"9766_CR34","doi-asserted-by":"crossref","unstructured":"Brabyn S, Araya R, Barkham M, Bower P, Cooper C, Duarte A, et al. The second randomised evaluation of the effectiveness, cost-effectiveness and acceptability of computerised therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trial. Health Technol Assess. 2016;20(89).","DOI":"10.3310\/hta20890"},{"issue":"14","key":"9766_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20140","volume":"20","author":"DA Richards","year":"2016","unstructured":"Richards DA, Bower P, Chew-Graham C, Gask L, Lovell K, Cape J, et al. Clinical effectiveness and cost-effectiveness of collaborative care for depression in UK primary care (CADET): a cluster randomised controlled trial. Health Technol Assess. 2016;20(14):1\u2013192.","journal-title":"Health Technol Assess"},{"key":"9766_CR36","doi-asserted-by":"publisher","DOI":"10.3310\/eme04020","author":"IM Anderson","year":"2017","unstructured":"Anderson IM, Blamire A, Branton T, Brigadoi S, Clark R, Downey D, et al. Randomised controlled trial of ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT study). Efficacy Mech Eval. 2017. https:\/\/doi.org\/10.3310\/eme04020.","journal-title":"Efficacy Mech Eval"},{"issue":"67","key":"9766_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21670","volume":"21","author":"K Bosanquet","year":"2017","unstructured":"Bosanquet K, Adamson J, Atherton K, Bailey D, Baxter C, Beresford-Dent J, et al. CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness. Health Technol Assess. 2017;21(67):1\u2013252.","journal-title":"Health Technol Assess"},{"key":"9766_CR38","doi-asserted-by":"publisher","DOI":"10.3310\/hta21350","author":"MB Gabbay","year":"2017","unstructured":"Gabbay MB, Ring A, Byng R, Anderson P, Taylor RS, Matthews C, et al. Debt counselling for depression in primary care: an adaptive randomised controlled pilot trial (DeCoDer study). Health Technol Assess. 2017. https:\/\/doi.org\/10.3310\/hta21350.","journal-title":"Health Technol Assess"},{"issue":"8","key":"9766_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21080","volume":"21","author":"H Lewis","year":"2017","unstructured":"Lewis H, Adamson J, Atherton K, Bailey D, Birtwistle J, Bosanquet K, et al. CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness. Health Technol Assess. 2017;21(8):1\u2013196.","journal-title":"Health Technol Assess"},{"issue":"46","key":"9766_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21460","volume":"21","author":"DA Richards","year":"2017","unstructured":"Richards DA, Rhodes S, Ekers D, McMillan D, Taylor RS, Byford S, et al. Cost and outcome of behavioural activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression. Health Technol Assess. 2017;21(46):1\u2013366.","journal-title":"Health Technol Assess"},{"issue":"53","key":"9766_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta22530","volume":"22","author":"A Jahoda","year":"2018","unstructured":"Jahoda A, Hastings R, Hatton C, Cooper SA, McMeekin N, Dagnan D, et al. Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT. Health Technol Assess. 2018;22(53):1\u2013130.","journal-title":"Health Technol Assess"},{"issue":"63","key":"9766_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta22630","volume":"22","author":"D Kessler","year":"2018","unstructured":"Kessler D, Burns A, Tallon D, Lewis G, MacNeill S, Round J, et al. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT. Health Technol Assess. 2018;22(63):1\u2013136.","journal-title":"Health Technol Assess"},{"key":"9766_CR43","doi-asserted-by":"publisher","DOI":"10.3310\/eme05070","author":"TR Lynch","year":"2018","unstructured":"Lynch TR, Hempel RJ, Whalley B, Byford S, Chamba R, Clarke P, et al. Radically open dialectical behaviour therapy for refractory depression: the RefraMED RCT. Efficacy Mech Eval. 2018. https:\/\/doi.org\/10.3310\/eme05070.","journal-title":"Efficacy Mech Eval"},{"key":"9766_CR44","doi-asserted-by":"publisher","DOI":"10.3310\/hta22300","author":"SH Richards","year":"2018","unstructured":"Richards SH, Campbell JL, Dickens C, Anderson R, Gandhi M, Gibson A, et al. Enhanced psychological care in cardiac rehabilitation services for patients with new-onset depression: the CADENCE feasibility study and pilot RCT. Health Technol Assess. 2018. https:\/\/doi.org\/10.3310\/hta22300.","journal-title":"Health Technol Assess"},{"key":"9766_CR45","doi-asserted-by":"publisher","DOI":"10.3310\/hsdr07250","author":"H Burroughs","year":"2019","unstructured":"Burroughs H, Bartlam B, Bullock P, Lovell K, Ogollah R, Ray M, et al. Non-traditional support workers delivering a brief psychosocial intervention for older people with anxiety and depression: the NOTEPAD feasibility study. Health Serv Deliv Res. 2019. https:\/\/doi.org\/10.3310\/hsdr07250.","journal-title":"Health Serv Deliv Res"},{"issue":"19","key":"9766_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta23190","volume":"23","author":"M Serfaty","year":"2019","unstructured":"Serfaty M, King M, Nazareth I, Moorey S, Aspden T, Tookman A, et al. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT. Health Technol Assess. 2019;23(19):1\u2013106.","journal-title":"Health Technol Assess"},{"key":"9766_CR47","doi-asserted-by":"crossref","unstructured":"Thomas SA, Drummond AE, Lincoln NB, Palmer RL, das Nair R, Latimer NR, et al. Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT. Health Technol Assess. 2019;23(47):1\u2013176.","DOI":"10.3310\/hta23470"},{"key":"9766_CR48","doi-asserted-by":"publisher","DOI":"10.3310\/phr09100","author":"A Ali","year":"2021","unstructured":"Ali A, McKenzie E, Rasoul Z, Hassiotis A, Priebe S, Lloyd-Evans B, et al. One-to-one volunteer befriending to reduce symptoms of depression in people with intellectual disability: a feasibility RCT. Public Health Res. 2021. https:\/\/doi.org\/10.3310\/phr09100.","journal-title":"Public Health Res"},{"key":"9766_CR49","doi-asserted-by":"publisher","DOI":"10.3310\/hta25690","author":"L Duffy","year":"2021","unstructured":"Duffy L, Clarke CS, Lewis G, Marston L, Freemantle N, Gilbody S, et al. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT. Health Technol Assess. 2021. https:\/\/doi.org\/10.3310\/hta25690.","journal-title":"Health Technol Assess"},{"key":"9766_CR50","doi-asserted-by":"publisher","DOI":"10.3310\/hta20640","author":"RK Simmons","year":"2016","unstructured":"Simmons RK, Borch-Johnsen K, Lauritzen T, Rutten GE, Sandbaek A, van den Donk M, et al. A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study. Health Technol Assess. 2016. https:\/\/doi.org\/10.3310\/hta20640.","journal-title":"Health Technol Assess"},{"key":"9766_CR51","doi-asserted-by":"publisher","DOI":"10.3310\/hta22180","author":"SJ Griffin","year":"2018","unstructured":"Griffin SJ, Bethel MA, Holman RR, Khunti K, Wareham N, Brierley G, et al. Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT. Health Technol Assess. 2018. https:\/\/doi.org\/10.3310\/hta22180.","journal-title":"Health Technol Assess"},{"key":"9766_CR52","doi-asserted-by":"crossref","unstructured":"House A, Bryant L, Russell AM, Wright-Hughes A, Graham L, Walwyn R, et al. Managing with learning disability and diabetes: OK-Diabetes \u2013 a case-finding study and feasibility randomised controlled trial. Health Technol Assess. 2018;22(26).","DOI":"10.3310\/hta22260"},{"key":"9766_CR53","doi-asserted-by":"crossref","unstructured":"Sivaprasad S, Hykin P, Prevost AT, Vasconcelos J, Riddell A, Ramu J, et al. Intravitreal aflibercept compared with panretinal photocoagulation for proliferative diabetic retinopathy: the CLARITY non-inferiority RCT. Efficacy Mech Eval. 2018;5(5).","DOI":"10.3310\/eme05050"},{"key":"9766_CR54","doi-asserted-by":"crossref","unstructured":"Sivaprasad S, Vasconcelos J, Holmes H, Murphy C, Kelly J, Hykin P, et al. Lightmasks that prevent dark adaptation for non-central diabetic macular oedema: the CLEOPATRA RCT. Efficacy Mech Eval. 2019; 6(2).","DOI":"10.3310\/eme06020"},{"key":"9766_CR55","doi-asserted-by":"crossref","unstructured":"Ruban A, Glaysher MA, Miras AD, Goldstone AP, Prechtl CG, Johnson N, et al. A duodenal sleeve bypass device added to intensive medical therapy for obesity with type 2 diabetes: a RCT. Efficacy Mech Eval. 2020;7(6).","DOI":"10.3310\/eme07060"},{"key":"9766_CR56","doi-asserted-by":"crossref","unstructured":"Hykin P, Prevost AT, Sivaprasad S, Vasconcelos JC, Murphy C, Kelly J, et al. Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT. Health Technol Assess. 2021;25(38).","DOI":"10.3310\/hta25380"},{"key":"9766_CR57","doi-asserted-by":"crossref","unstructured":"Khunti K, Griffin S, Brennan A, Dallosso H, Davies M, Eborall H, et al. Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT. Health Technol Assess. 2021;25(77).","DOI":"10.3310\/hta25770"},{"key":"9766_CR58","doi-asserted-by":"crossref","unstructured":"Miras AD, Kamocka A, Tan T, Perez-Pevida B, Chahal H, Moorthy K, et al. Long limb compared with standard limb Roux-en-Y gastric bypass for type 2 diabetes and obesity: the LONG LIMB RCT. Efficacy Mech Eval. 2021;8(3).","DOI":"10.3310\/eme08030"},{"key":"9766_CR59","volume-title":"Common European Framework of Reference for Languages: learning, teaching, assessment","author":"Council of Europe","year":"2001","unstructured":"Council of Europe. Common European Framework of Reference for Languages: learning, teaching, assessment. Cambridge: Cambridge University Press; 2001."},{"key":"9766_CR60","doi-asserted-by":"publisher","unstructured":"Venegas J, Clark E. Wechsler Test of Adult Reading. In: Kreutzer JS, DeLuca J, Caplan B, editors. Encyclopedia of clinical neuropsychology. New York (NY): Springer; 2011. https:\/\/doi.org\/10.1007\/978-0-387-79948-3_1500.","DOI":"10.1007\/978-0-387-79948-3_1500"},{"key":"9766_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100252","volume":"11","author":"BE Turner","year":"2022","unstructured":"Turner BE, Steinberg JR, Weeks BT, Rodriguez F, Cullen MR. Race\/ethnicity reporting and representation in US clinical trials: a cohort study. Lancet Reg Health Am. 2022;11:100252. https:\/\/doi.org\/10.1016\/j.lana.2022.100252.","journal-title":"Lancet Reg Health Am"},{"key":"9766_CR62","unstructured":"Scholes A, Sivathasan C, Morton G, Bailey K. UK and US attitudes: two sides of the same coin? London: National Centre for Social Research; 2025. Available from: https:\/\/natcen.ac.uk\/publications\/uk-and-us-attitudes-two-sides-same-coin"},{"issue":"1","key":"9766_CR63","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/weng.12303","volume":"37","author":"L Ortega","year":"2018","unstructured":"Ortega L. Ontologies of language, second language acquisition, and world Englishes. World Engl. 2018;37(1):64\u201379.","journal-title":"World Engl"},{"issue":"7","key":"9766_CR64","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1016\/S2468-2667(21)00100-6","volume":"6","author":"A Willis","year":"2021","unstructured":"Willis A, Isaacs T, Khunti K. Improving diversity in research and trial participation: the challenges of language. Lancet Public Health. 2021;6(7):e445\u20136.","journal-title":"Lancet Public Health"},{"issue":"1","key":"9766_CR65","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s13063-024-08471-5","volume":"25","author":"V Wylde","year":"2024","unstructured":"Wylde V, Brennan S, Johnson E, Roberts K, Beswick AD, Jameson C. Recommendations for developing accessible patient information leaflets for clinical trials to address English language literacy as a barrier to research participation. Trials. 2024;25(1):624.","journal-title":"Trials"},{"issue":"6","key":"9766_CR66","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/10410236.2011.558336","volume":"26","author":"T Isaacs","year":"2011","unstructured":"Isaacs T, Laurier MD, Turner CE, Segalowitz N. Identifying second language speech tasks and ability levels for successful nurse oral interaction with patients in a linguistic minority setting: an instrument development project. Health Commun. 2011;26(6):560\u201370.","journal-title":"Health Commun"},{"issue":"1","key":"9766_CR67","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s13063-025-08938-z","volume":"26","author":"S Treweek","year":"2025","unstructured":"Treweek S, Dawson S, Khunti K, Akand M, Briel M, da Costa B, et al. Who is in your trial? Improving the reporting of participant characteristics in trial protocols and results. Trials. 2025;26(1):338.","journal-title":"Trials"},{"issue":"1","key":"9766_CR68","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10903-022-01368-y","volume":"25","author":"AJ Zeidan","year":"2023","unstructured":"Zeidan AJ, Smith M, Leff R, Cordone A, Moran TP, Brackett A, et al. Limited English proficiency as a barrier to inclusion in emergency medicine-based clinical stroke research. J Immigr Minor Health. 2023;25(1):181\u20139.","journal-title":"J Immigr Minor Health"},{"key":"9766_CR69","unstructured":"U.S. Department of Commerce U.S. Census Bureau. People that speak English less than \u201cvery well\u201d in the United States. Internet. United States Census Bureau; 2020. Available from: https:\/\/www.census.gov\/library\/visualizations\/interactive\/people-that-speak-english-less-than-very-well.html"},{"key":"9766_CR70","volume-title":"How languages are learned","author":"PM Lightbown","year":"2013","unstructured":"Lightbown PM, Spada N. How languages are learned. 4th ed. Oxford: Oxford University Press; 2013.","edition":"4th ed"},{"issue":"2","key":"9766_CR71","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/02655322221100115","volume":"40","author":"AKH Gujord","year":"2023","unstructured":"Gujord AKH. Who succeeds and who fails? Exploring the role of background variables in explaining the outcomes of L2 language tests. Lang Test. 2023;40(2):227\u201348.","journal-title":"Lang Test"},{"issue":"1","key":"9766_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-024-08710-9","volume":"26","author":"JK Aronson","year":"2025","unstructured":"Aronson JK, Onakpoya IJ. Clinical study reports-a systematic review with thematic synthesis: Part 1. history, contents and structure, definitions, and terminology. Trials. 2025;26(1):141. https:\/\/doi.org\/10.1186\/s13063-024-08710-9.","journal-title":"Trials"},{"issue":"9","key":"9766_CR73","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.32312","volume":"8","author":"M Martos","year":"2025","unstructured":"Martos M, Fields B, Finlayson SG, Hartell N, Kim T, Larimer E, et al. Accuracy of artificial intelligence vs professionally translated discharge instructions. JAMA Netw Open. 2025;8(9):e2532312.","journal-title":"JAMA Netw Open"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09766-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09766-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09766-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:38:06Z","timestamp":1783550286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09766-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9766"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09766-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethics approval for secondary analysis from the UCL Institute of Education (IoE) Research Ethics approval, REC 1481.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ST is former co-Editor-in-Chief of Trials, MS is Senior Editor, KB, NN, LR, FS, are Associate Editors, and ST and KK are co-Editors of the special issue on Improving equity, diversity, and inclusion in randomised trials. MAD has contributed to the development of Option Grid patient decision aids. EBSCO Information Services sells subscription access to Option Grid patient decision aids. She receives consulting income from EBSCO Health, and royalties. No other competing interests declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"476"}}